Role of interleukin‐1, tumor necrosis factor α, and interleukin‐6 in cartilage proteoglycan metabolism and destruction effect of in situ blocking in murine antigen‐ and zymosan‐induced arthritis

Arthritis & Rheumatism

Volumn 38, Issue 2, 1995, Pages 164-172

  Loo, Fons A J Van De ^a   Joosten, Leo A B ^a   Van Lent, Peter L E M ^a   Arntz, Onno J ^a   Van Den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS; ARTICLE; CARTILAGE DEGENERATION; DRUG INDUCED DISEASE; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN METABOLISM;

ANIMAL; ANTIBODY FORMATION; ANTIGENS; ARTHRITIS; CARTILAGE, ARTICULAR; CYTOKINES; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MICE; PROTEOGLYCANS; RECEPTORS, INTERLEUKIN-1; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR; ZYMOSAN;

EID: 0028891167     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780380204     Document Type: Article

References (36)

1. Localization of interleukin‐1α, type 1 interleukin‐1 receptor and interleukin‐1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis
2. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis
3. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis
4. Synovial fluid concentration of five different cytokines in rheumatic diseases
5. Cytokine production in the rheumatoid joint: implications for treatment
6. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation
7. Interleukin 1, tumor necrosis factor, and interleukin 6 as mediators of cartilage destruction
8. Inhibitory effect of TNFα antibodies on synovial cell interleukin‐1 production in rheumatoid arthritis
9. IL‐6 production by human articular chondrocytes: modulation of its synthesis by cytokines, growth factors, and hormones in vitro
10. Synovium as a source of interleukin 6 in vitro contribution to local and systemic manifestations of arthritis
11. Interleukin‐1‐induced interleukin‐6 is required for the inhibition of proteoglycan synthesis by interleukin‐1 in human articular cartilage
12. In vivo studies of articular tissue damage mediated by catabolin/interleukin 1
13. Effects of murine recombinant interleukin 1 on synovial joints in mice: measurements of patellar cartilage metabolism and joint inflammation
14. Arthritogenic actions of recombinant IL‐1 and tumour necrosis factor α in the rabbit: evidence for synergistic interactions between cytokines in vivo
15. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin‐1 and tumor necrosis factor
16. Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage
17. Effects of IL‐1β and tumor necrosis factor α on cartilage proteoglycan metabolism in vitro
18. The effect of an interleukin‐1 receptor antagonist protein on type II collagen‐induced arthritis and antigen‐induced arthritis in mice
19. Amelioration of established murine collagen induced arthritis with anti‐IL‐1 treatment
20. Anti‐tumor necrosis factor ameliorates joint disease in murine collagen‐induced arthritis
21. Evolution of collagen arthritis is arrested by treatment with anti‐tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor
22. involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice
23. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen‐induced arthritis in mice
24. Antigen‐induced arthritis in mice. I. Induction of arthritis in various strains of mice
25. Zymosan‐induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement
26. Tumour necrosis factor (TNF‐α) and interleukin 6 in a zymosan‐induced shock model
27. Measurement of interleukin‐1 liberation in zymosan air‐pouch exudate in mice
28. Generation of monoclonal antibodies to murine IL‐1β and demonstration of IL‐1 in vivo
29. Improved quantitation of sulfated glycosaminoglycans by use of dimethylmethylene blue
30. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint
31. Effects of interleukin‐6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts
32. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
33. Interleukin‐1 receptor antagonist blocks interleukin‐1‐induced synovitis, but not antigen‐induced arthritis in the rabbit (abstract)
34. The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen‐induced arthritis in the rabbit
35. Biologic effects of an interleukin‐1 receptor antagonist protein on interleukin‐1‐stimulated cartilage erosion and chondrocyte responsiveness
36. Amelioration of established collagen‐induced arthritis (CIA) with anti‐IL‐1